Navitor Transcatheter Aortic Valve Implantation System
ABBOTT MEDICAL · Decision date May 26, 2026
What did the FDA decide?
FDA records P190023/S032 as a supplement to PMA P190023, with the supplement type “30-Day Notice”. The recorded decision is OK30 (30-day notice), dated May 26, 2026.
FDA approval order statement
a manufacturing process enhancement to the application of pouch and tray labels
- Regulatory pathway
- PMA supplement
- Supplement type
- 30-Day Notice
- Clinical specialty
- Cardiovascular
- Decision date
- May 26, 2026
- FDA change category
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
Regulatory record facts
- Identifier
- P190023/S032
- Regulatory pathway
- PMA supplement
- Applicant
- ABBOTT MEDICAL
- Product code
- NPT
- Decision code
- OK30
- Decision date
- May 26, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Aortic valve, prosthesis, percutaneously delivered.
- Applicant
- Abbott Medical
- Product code
- NPT
- FDA device class
- 3
For the original device and its historical approval scope, see PMA P190023. Subsequent supplements may change the device or its indications.
FDA decision timeline
P190023 · Original PMA
Portico Transcatheter Aortic Valve Implantation System
P190023/S026 · Related supplement
Navitor Transcatheter Aortic Valve
P190023/S027 · Related supplement
Navitor Transcatheter Aortic Valve Implantation System
P190023/S028 · Related supplement
FlexNav Delivery System; Navitor Transcatheter Aortic Valves
P190023/S031 · Related supplement
Navitor Transcatheter Aortic Valve Implantation System
P190023/S030 · Related supplement
Navitor Transcatheter Aortic Valve Implantation System
P190023/S032 received
Application receipt date recorded by FDA.
P190023/S032 · FDA decision
30-Day Notice
P190023/S029 · Related supplement
Navitor TAVI System with Vision Technology
P190023/S034 · Related supplement
Navitor Transcatheter Aortic Valve Implantation System
P190023/S033 · Related supplement
Navitor Transcatheter Aortic Valve Implantation System
Timeline entries are records held by MedtechLedger for P190023. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P190023
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| ABBOTT MEDICAL | PMA approval | Sep 17, 2021 | FDA | |
Navitor Transcatheter Aortic ValveP190023/S026 | ABBOTT MEDICAL | PMA supplement | Jul 29, 2025 | FDA |
| ABBOTT MEDICAL | PMA supplement | Sep 22, 2025 | FDA | |
| ABBOTT MEDICAL | PMA supplement | Oct 15, 2025 | FDA | |
| ABBOTT MEDICAL | PMA supplement | Mar 17, 2026 | FDA | |
| ABBOTT MEDICAL | PMA supplement | Apr 15, 2026 | FDA | |
Navitor TAVI System with Vision TechnologyP190023/S029 | ABBOTT MEDICAL | PMA supplement | Jun 3, 2026 | FDA |
| ABBOTT MEDICAL | PMA supplement | Jul 9, 2026 | FDA | |
| ABBOTT MEDICAL | PMA supplement | Oct 29, 2026 | FDA |
Explore the linked device profile
Other records with product code NPT
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Medtronic, Inc. | PMA supplement | Nov 7, 2026 | FDA | |
| Edwards Lifesciences, LLC | PMA supplement | Oct 28, 2026 | FDA | |
| Edwards Lifesciences, LLC | PMA supplement | Oct 22, 2026 | FDA | |
Trilogy Transcatheter Heart Valve SystemP250024/S005 | JenaValve Technology, Inc. | PMA supplement | Oct 13, 2026 | FDA |
Trilogy Transcatheter Heart Valve SystemP250024/S006 | JenaValve Technology, Inc. | PMA supplement | Oct 7, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Abbott Medical
- Headquarters
- Not reported
- Brand website
- abbott.com
- FDA applicant address
- 177 County Rd. B E., St. Paul, MN, 55117
Sources and methodology
- Original FDA record: P190023/S032
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 21, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records
